Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells

Microbes and Infection

Volumn 5, Issue 2, 2003, Pages 123-133

  Malhotra, Rajneesh ^a   Ward, Malcolm ^a   Bright, Helen ^a   Priest, Richard ^a   Foster, Martyn R ^a   Hurle, Michael ^a   Blair, Eddie ^a   Bird, Michael ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Annexin II; Fucoidan; G Protein; RSV; TBC1269

Indexed keywords

ANNEXIN; BIMOSIAMOSE; LECTIN; POLYSACCHARIDE; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; RECEPTOR BINDING; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

MAMMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 0037297758     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00079-5     Document Type: Article

References (33)

1. Shay D.K., Holman R.C., Newman R.C., Liu L.L., Stout J.W., Anderson L.J. Bronchiolitis associated hospitalisations among children 1980-1996. J. Am. Med. Assoc. 282:1999;1440-1446.
2. Falsey A.R., Cunningham C.K., Barker W.H., Kouides R.W., Yuen J.B., Menegus M., Weiner L.B., Bonville C.A., Betts R.F. Respiratory syncytial virus and Influenza virus A infections in the hospitalised elderly. J. Inf. Dis. 172:1995;389-394.
3. Collins P.L., Chanock R.M., Murphy B.R. Respiratory syncytial virus. Knipe D.M., Howley P.M. Fields Virology. 4th:2001;1443-1485 Lippincott, Williams and Wilkins, Philadelphia, PA.
4. Lambert D.M. Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology. 164:1988;458-466.
5. Martinez I., Melero J.A. Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J. Gen. Virol. 81:2000;2715-2722.
6. Trip R.A., Jones L.P., Haynes L.M., Zheng H., Murphy P.M., Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2:2001;732-738.
7. Malhotra R., Ward M., Sim R.B., Bird M.I. Identification of human complement factor H as a ligand for L-selectin. Biochem. J. 341:1999;61-69.
8. Kogan T.P., Dupre B., Bui H., Mcabee K.L., Kassir J.M., ScottI L.L., Hu X., Vanderslice P.J., Dixon R.A.F. Novel synthetic inhibitors of selectin-mediated cell adhesion - synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-d-mannopyranosyloxy)phenyl] hexane (TBC1269). J. Med. Chem. 41:1998;1099-1111.
9. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-985.
10. Wilm M., Shevchenko A., Houthaeve T., Breit S., Schweigerer L., Fotsis T., Mann M. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature. 379:1996;466-469.
11. Jensen O.N., Podtelejnikov A.V., Mann M. Identification of the components of simple protein mixtures by high-accuracy peptide mass mapping and database searching. Anal. Chem. 69:1997;4741-4750.
12. Mann M., Hojrup P., Roepstorff P. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol. Mass Spectrom. 22:1993;338-345.
13. Wilm M., Mann M. Analytical properties of the nanoelectrospray ion source. Anal. Chem. 68:1996;1-8.
14. Bonner R., Shushan B. The characterization of proteins and peptides by automated methods. Rapid Commun. Mass Spectrom. 9:1996;1067-1076.
15. Mann M., Wilm M. Electrospray mass spectrometry for protein characterization. Trends Biochem. Sci. 20:1995;219-224.
16. Hajjar K.A., Jacovina A.T., Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 269:1994;21191-21197.
17. Abraham W.M., Ahmed A., Sabater J.R., Lauredo I.T., Botvinnikova Y., Bjercke R.J., Hu X., Revelle B.M., Kogan T.P., Scott I.L., Dixon R.A.F., Yeh E.T.H., Beck P.J. Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am. J. Respir. Crit. Care M. 159:1999;1205-1214.
18. Rosen S.J., Bertozzi C.R. Two selectins converge on sulphate. Leukocyte adhesion. Curr. Biol. 6:1996;261-264.
19. Malhotra R., Bird M.I. L-Selectin-a novel receptor for lipopolysaccharide and its potential role in bacterial sepsis. Bioessays. 19:1997;919-923.
20. Bourgeois C., Bour J.B., Lidholt K., Gauthray C., Pothier P. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J. Virol. 72:1998;7221-7227.
21. Brown R.S., Lennon J.J. Mass resolution improvement by incorporation of pulsed ion extraction in a matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometer. Anal. Chem. 67:1995;1998-2003.
22. Kassam G., Manro A., Braat C.E., Louie P., Fitzpatrick S.L., Waisman D.M. Characterization of the heparin binding properties of annexin II tetramer. J. Biol. Chem. 272:1997;15093-15100.
23. Meert K.L., Sarnaik A.P., Gelmini M.J., Lieh-Lai M.W. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit. Care M. 22:1994;566-572.
24. Groothuis J.R., Simoes E.A., Levin M.J., Hall C.B., Long C.E., Rodriguez W.J., Arrobio J., Meissner H.C., Fulton D.R., Welliver R.C. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The respiratory syncytial virus immune globulin study group. New Engl. J. M. 329:1993;1524-1530.
25. Simoes E.A.F., Sondheimer H.M., Top Jr F.H., Meissner H.C., Welliver R.C., Kramer A.A., Groothuis J.R. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. J. Pediatrics. 133:1998;492-499.
26. Swairjo M.A., Concha N.O., Kaetzel M.A., Dedman J.R., Seaton B.A. Ca(2+)-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nat. Struct. Biol. 2:1995;968-974.
27. Chung C.Y., Erickson H.P. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J. Cell Biol. 126:1994;539-548.
28. Wright J.F., Kurosky A., Wasi S. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun. 198:1994;983-989.
29. Dreier R., Schmid K.W., Greke V., Reihemann K. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histchem. Cell Biol. 110:1998;137-148.
30. Srivastava M., Pollard H.B. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 13:1999;1911-1922.
31. Fitzpatrick S.L., Kassam G., Manro A., Braat C.E., Louie P., Waisman D.M. Fucoidan dependent conformational changes in Annexin II tetramer. Biochemistry. 39:2000;2140-2148.
32. Johnson S., Oliver C., Prince G.A., Hemming V.G., Pfarr D.S., Wang S.C., Dormitzer M., O'Grady J., Koenig S., tamura J.K., Woods R., Bansal G., Couchenour D., Tsao E., Hall W.C., Young J.F. Development of a humanised monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J. Inf. Dis. 176:1997;1215-1224.
33. Palivizumab, a humanised respiratory syncytial virus monoclonal antibody, reduces hospitalisation from respiratory syncytial virus infection in high risk infants. Pediatrics. 102:1998;531-537.